Page last updated: 2024-11-04

succinylcholine and Hyperparathyroidism

succinylcholine has been researched along with Hyperparathyroidism in 2 studies

Succinylcholine: A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.
succinylcholine : A quaternary ammonium ion that is the bis-choline ester of succinic acid.

Hyperparathyroidism: A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Luccarelli, J1
Fernandez-Robles, C1
Berg, SM1
Henry, ME1
Al-Mohaya, S1
Naguib, M1
Abdelatif, M1
Farag, H1

Other Studies

2 other studies available for succinylcholine and Hyperparathyroidism

ArticleYear
Bilateral Forearm Fractures During Modified Electroconvulsive Therapy in a Male Patient With a History of Hyperparathyroidism and Elevated Pseudocholinesterase Activity.
    The journal of ECT, 2019, Volume: 35, Issue:3

    Topics: Aged; Anesthesia; Arm Injuries; Butyrylcholinesterase; Depressive Disorder, Major; Depressive Disord

2019
Abnormal responses to muscle relaxants in a patient with primary hyperparathyroidism.
    Anesthesiology, 1986, Volume: 65, Issue:5

    Topics: Adenoma; Anesthesia; Atracurium; Cholinesterases; Halothane; Hemodynamics; Humans; Hyperparathyroidi

1986